Formula 01 sachet on a blue gradient

The layer topical skincare can't reach

The layer skincare can't reach

Why skin needs support from within, and what systemic delivery can do that a cream cannot.

Key points

  • Skin is fed from below. The epidermis has no blood supply of its own, and every living cell in it depends on what diffuses up from capillaries in the dermis.
  • The skin barrier is built to keep molecules out, and it works. Most topical actives act at or near the surface. The dermis, where collagen is made, is the compartment they reach least.
  • Skin reads the body. How old a face looks predicts survival and rises with blood glucose.
  • With age, the supply line thins. Older skin has roughly 40% fewer nutritive capillary loops, just as repair demand rises.
  • Skincare stayed at the surface for legal, clinical, and commercial reasons, not scientific ones.
  • Systemic support is the foundation layer. It complements topicals and procedures. It does not replace them.

Skin is fed from below

Skincare has been an outside-in discipline for as long as it has existed. We cleanse the surface, protect it, and apply actives to it. Procedures go deeper, but they too start at the surface and work inward.

The biology runs the other way. The epidermis has no blood vessels of its own. Every living keratinocyte depends on oxygen and nutrients diffusing upward from the capillary loops of the papillary dermis, the nutritive component of the skin's circulation [1]. Fibroblasts, the cells that build and maintain the dermal matrix, sit inside that vascular supply. The raw materials, cofactors, and signals they work with arrive in the blood.

That is the layer skincare can't reach. It is not a depth in the tissue. It is a direction of supply.

This essay sets out why that layer matters, what reaching it can and cannot do, and why it belongs at the foundation of any serious skin longevity plan.

Skin reads the body

The case starts with something clinicians observe every day without naming it: skin shows systemic health.

Perceived age is a biomarker. In 1,826 Danish twins aged 70 and older, how old a person looked in a photograph predicted survival, even after adjusting for chronological age, sex, and rearing environment. The older-looking twin of a pair was more likely to die first, and perceived age tracked physical function, cognition, and leucocyte telomere length [2].

Metabolism shows on the face. In the Leiden Longevity Study, perceived age rose by 0.4 years for every 1 mmol/L increase in serum glucose in people without diabetes, after adjusting for sun damage, smoking, and body mass index [3]. Diabetes, the sustained form of the same exposure, accelerates the accumulation of glycation products in skin collagen [4].

Diet shows in the skin. In 4,025 women in the first US National Health and Nutrition Examination Survey, dermatologist-assessed wrinkling, senile dryness, and atrophy were associated with nutrient intakes, independent of age, sun exposure, income, and supplement use [5]. Across four populations, dietary patterns explained about a third of the variance in wrinkling at a sun-exposed site [6]. These are associations, not trials, but they point the same way.

Deficiency announces itself in skin. Many classic nutritional deficiency syndromes are recognized by their cutaneous signs, which often herald the systemic disease behind them [7].

The traffic runs both ways. Skin aging and systemic aging influence each other [8]. In aged mice, a failing epidermal barrier raises circulating inflammatory cytokines, and repairing it brings them down [9]. A pilot study in older adults found the same with a topical emollient [10].

Skin is not a surface sitting on top of the body. It is an organ supplied by the same blood, exposed to the same metabolic environment, and aging through the same mechanisms: mitochondrial decline, glycation, senescence, failing protein turnover, chronic inflammation. None of these is unique to skin. They run throughout the body and show up in skin as part of that wider biology. An approach that works only at the surface leaves those inputs untouched.

The barrier is doing its job

The stratum corneum is the most effective barrier the body builds. On the cheek it is about 17 micrometers thick [11], roughly a sixth of a sheet of paper, and it exists to keep molecules out. It succeeds. Passive penetration across intact skin falls off steeply above about 500 daltons: nearly all contact allergens, nearly all topical dermatological drugs, and every compound used in transdermal delivery sit below that line [12]. Many peptides, proteins, and polysaccharides are tens to thousands of times larger.

That does not make topicals ineffective. Small, well-formulated actives do reach living tissue. Topical retinol applied to the arms of adults with a mean age of 87 reduced fine wrinkling and raised procollagen I and glycosaminoglycan expression in the dermis over 24 weeks [13]. Sunscreen prevents damage nothing taken by mouth can match. Barrier repair has measurable effects well beyond the skin [10].

But what a topical delivers depends on molecular size, formulation, concentration, and site, and most of it acts at or near the surface. The dermis, where collagen is made and where the slowest and most consequential aging happens, is the compartment topicals reach least. Exposure also stops where the product stops: at the jawline, the neck, the backs of the hands, the skin never treated at all.

Supply from below, and why it thins

The systemic route approaches the same organ from the opposite side. Once absorbed, nutrients, metabolites, and bioactive compounds reach skin through its circulation, arriving in the dermis first and the epidermis by diffusion [1]. They do not have to cross the barrier, and they are not limited to where something was applied.

Skin cells do not simply wait for whatever drifts past. They take up many circulating nutrients through dedicated membrane transporters, the same physiological route skin has always used to supply itself.

Aging adds a problem: the supply line thins. Using video capillaroscopy, Kelly and colleagues counted 40% fewer dermal papillary loops in older forehead skin and 37% fewer on the forearm than in young skin. They concluded that a marked loss of nutritive vessel density, and of the surface area available for exchange, is a feature of both chronological aging and photoaging [14, 15].

Demand rises with age as damage accumulates and repair slows. Delivery falls at the same time. That mismatch is a core part of the rationale for systemic support: what arrives through a thinner supply line has to count.

Why skincare never built this layer

If the biology is this clear, why has skincare stayed at the surface? There are three reasons, and none of them is scientific.

The law drew the line at the surface. Under US law, a cosmetic is a product applied to the body "for cleansing, beautifying, promoting attractiveness, or altering the appearance." A product intended "to affect the structure or any function of the body" is a drug [16]. A beauty industry built on cosmetics was confined, by definition, to appearance. The biology beneath the surface belonged to pharmaceuticals.

Clinical practice followed its tools. Dermatology and aesthetic medicine grew up around what can be applied, injected, or delivered as energy at the skin. Nutrition sat in another specialty, and its skin literature stayed scattered across journals few dermatologists read.

The supplement category earned its skepticism. "Beauty from within" has mostly been sold as gummies and powders: marketing-led formulations, under-dosed actives, little human skin data. A comprehensive review of human clinical studies of skin nutraceuticals found real signals across several ingredient classes, and concluded that trial quality and rigor must improve before cause and effect can be established [17]. Clinicians who dismissed the category were mostly reacting to the products, not the biology.

The result is a gap. The most sophisticated part of skin care, clinical and aesthetic practice, has the least to say about the supply side of the organ it treats.

What systemic support contributes

Four contributions matter most. The first three are the scientific case. The fourth is why it holds up in real life.

1. It reaches the dermis from the side the dermis is fed from

The dermis is where skin aging becomes structural. It holds the collagen that takes about 15 years to turn over [20], the fibroblasts that make it, and the glycosaminoglycan matrix that holds water. It is also the compartment topicals reach least.

Fibroblasts live inside the capillary network. The raw materials, cofactors, and energy substrates they build with all arrive in the blood. Systemic delivery meets them where they are already supplied, instead of asking a molecule to cross 17 micrometers of barrier and the living epidermis beneath it first.

This is also where time matters. Dermal renewal runs on a clock of months and years. A supply that is present every day, rather than in pulses after each application, matches the pace of the work. Actual exposure still depends on the compound: how well it is absorbed, how long it circulates, and how readily skin cells take it up.

2. It can support the network, not one node

In our map of skin aging, ten factors across three layers are coupled into circuits. Oxidative stress raises the metalloproteinases. Fragmented collagen raises oxidative stress. Senescent cells spread inflammation, and inflammation degrades the matrix. Interrupting one link slows a loop. Leaving the others intact lets it restart.

A topical is a poor vehicle for a network. Every active added to a cream competes for the same small volume and the same formulation constraints. Some actives need different pH ranges. Some oxidize on contact with air or light. Some destabilize one another, and many cannot penetrate at all. In practice, many topicals are built around a single hero active, and multi-active care turns into a layering routine.

An oral formulation is not bound by those limits in the same way. Ingredients that could never share a jar can share a daily intake, so the network can be supported at several points at once: load, machinery, and structure together. That is the logic of a multi-target formula. It also raises the evidence bar rather than lowering it. Every active has to earn its place at a dose with human data.

3. It reaches drivers that don't start in skin

Some of what ages skin is made elsewhere and delivered by the blood.

  • Blood glucose drives glycation. Higher glucose tracks with an older-looking face even without diabetes [3], and in diabetes, glycation products build up faster in skin collagen [4]. Glycated collagen is harder to remodel, and with a 15-year half-life the tissue carries that damage for years [20].
  • Inflammation circulates. Low-grade inflammatory tone rises with age across the body. Skin both receives it and contributes to it: in aged mice, and in a pilot study in older adults, barrier status moved circulating cytokine levels [9, 10].
  • Nutrient status shows. Dietary intake tracks with dermatologist-assessed wrinkling and dryness [5, 6], and deficiency often shows first in skin [7].
  • The gut talks to skin. Gut-derived signals shape skin differentiation and immune tone [19].

None of these can be reached at an application site. A cream can intercept damage once it arrives in the tissue. It cannot change what the blood is carrying.

4. It covers the whole organ, every day

The last contribution is practical, and it is where many good regimens fail.

  • Every site, not just the treated one. The neck, décolletage, and backs of the hands are among the most visible sites of aging and the most often left out of a routine. Circulation supplies them all.
  • A defined dose. A topical dose varies with how much is dispensed, how evenly it is spread, and what is lost to rubbing, sweat, and cleansing. An oral dose is specified and reproduced, though absorption still differs between people.
  • Continuous availability. Supply is maintained, rather than rising and falling between applications.
  • A routine that holds. Poor adherence to topical regimens is common and is a leading reason dermatologic treatments underperform [18]. Every step is a point of failure. One daily intake removes most of them.

A foundation for the aesthetic care plan

Every aesthetic procedure, from microneedling to resurfacing lasers to collagen stimulators, works by asking skin to respond. A controlled injury or stimulus goes in. The result depends on how well the tissue repairs and rebuilds.

That response is biology, and biology has inputs. Wound healing is delayed in healthy older adults [21]. Nutritional deficiency impairs it at every stage, from inflammation to matrix deposition to the tensile strength of the repaired tissue [22]. Yet aged fibroblasts still respond when given the right cues. When structural support was restored in aged human skin with an injected dermal filler, fibroblasts spread out and resumed type I collagen production [23]. Capacity remains. It needs the conditions to express itself.

We see systemic support as the foundation of the care plan, the layer every other intervention stands on:

  • Procedures provide the stimulus.
  • Topicals provide local exposure, photoprotection, and barrier support.
  • Systemic support aims to keep the tissue receiving them supplied for the work they ask of it.

What it can't do

Systemic delivery has real constraints, and a credible approach starts with understanding their limits.

  • A swallowed dose is not a skin dose. Compounds differ in absorption, first-pass metabolism, half-life, tissue partitioning, and uptake into skin. Skin is rarely the main destination for a circulating nutrient, so alternative dosages are required for skin specific outcomes. 
  • Topicals win on local concentration. They can reach levels at the surface that would be impractical or undesirable systemically. Nothing taken by mouth replaces sunscreen.
  • Biology sets the pace. The stratum corneum takes about 20 days to renew in young adults, and more than 30 in older ones [24]. Dermal collagen has an estimated half-life of about 15 years [20]. Structural change is slow by design, but last the longest.

These constraints define the standard any systemic skin product should meet. Choose actives at doses with human skin-endpoint data wherever that data exists. Where it does not, separate established human outcomes from mechanistic rationale, and say so. That is the standard we hold ourselves to.

Inside and outside

Topical care and systemic support are complementary, not interchangeable. Topicals provide high local exposure, photoprotection, barrier support, and direct action on cutaneous pathways. Systemic support reaches the cellular systems, metabolic inputs, and renewal processes that outside-in care cannot. FORMULA 01™ was designed for that inside-out role, as the foundation beneath topicals and procedures.

The longevity of skin, like that of the body, is not achieved by constantly replacing what is lost. It comes from supporting the systems that know how to make and maintain it.

References

  1. Braverman IM. The cutaneous microcirculation. J Investig Dermatol Symp Proc. 2000;5(1):3–9. doi
  2. Christensen K, Thinggaard M, McGue M, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ. 2009;339:b5262. doi
  3. Noordam R, Gunn DA, Tomlin CC, et al. High serum glucose levels are associated with a higher perceived age. Age (Dordr). 2013;35(1):189–195. doi
  4. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91(6):2463–2469. doi
  5. Cosgrove MC, Franco OH, Granger SP, Murray PG, Mayes AE. Dietary nutrient intakes and skin-aging appearance among middle-aged American women. Am J Clin Nutr. 2007;86(4):1225–1231. doi
  6. Purba MB, Kouris-Blazos A, Wattanapenpaiboon N, et al. Skin wrinkling: can food make a difference? J Am Coll Nutr. 2001;20(1):71–80. doi
  7. Jen M, Yan AC. Syndromes associated with nutritional deficiency and excess. Clin Dermatol. 2010;28(6):669–685. doi
  8. Furman D, Auwerx J, Bulteau AL, et al. Skin health and biological aging. Nat Aging. 2025;5(7):1195–1206. doi
  9. Hu L, Mauro TM, Dang E, et al. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137(6):1277–1285. doi
  10. Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197–2201. doi
  11. Egawa M, Hirao T, Takahashi M. In vivo estimation of stratum corneum thickness from water concentration profiles obtained with Raman spectroscopy. Acta Derm Venereol. 2007;87(1):4–8. doi
  12. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–169. doi
  13. Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606–612. doi
  14. Kelly RI, Pearse R, Bull RH, Leveque JL, de Rigal J, Mortimer PS. The effects of aging on the cutaneous microvasculature. J Am Acad Dermatol. 1995;33(5 Pt 1):749–756. doi
  15. Chung JH, Eun HC. Angiogenesis in skin aging and photoaging. J Dermatol. 2007;34(9):593–600. doi
  16. US Food and Drug Administration. Is it a cosmetic, a drug, or both? (Or is it soap?). FD&C Act sec. 201(i) and 201(g)(1). fda.gov
  17. Pérez-Sánchez A, Barrajón-Catalán E, Herranz-López M, Micol V. Nutraceuticals for skin care: a comprehensive review of human clinical studies. Nutrients. 2018;10(4):403. doi
  18. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231–236. doi
  19. Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459. doi
  20. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–39031. doi
  21. Gosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004;28(3):321–326. doi
  22. Stechmiller JK. Understanding the role of nutrition and wound healing. Nutr Clin Pract. 2010;25(1):61–68. doi
  23. Quan T, Wang F, Shao Y, et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Invest Dermatol. 2013;133(3):658–667. doi
  24. Grove GL, Kligman AM. Age-associated changes in human epidermal cell renewal. J Gerontol. 1983;38(2):137–142. doi
Back to blog